You are here

Fortis gets approval from Hero-Burman to reopen bidding


FORTIS Healthcare Ltd on Monday said that the consortium of Hero Enterprise Investment Office and Burman Family Office, which won a five-way bidding war for the Indian firm, has permitted reopening the bidding process, amid shareholder concerns over the board's choice of the underdog.

Though permitted to reopen the bidding, Fortis had not yet made a decision on the matter, a spokesperson said.

The board of the cash-strapped company approved the consortium's offer to invest 18 billion rupees (S$358.4 million) earlier this month.

However, investors have been wary of the board's selection, given that the consortium's offer was much lower than those of Manipal Hospitals Enterprises or Malaysia's IHH Healthcare Bhd.

In a letter to the company's board on Monday, the Hero-Burman group acknowledged stakeholders' preference for reopening the bidding process.

"We believe that this situation may have arisen largely on account of the lack of information available to stakeholders," Hero-Burman said.

Disapproval from shareholders became evident after they voted out a director last week. Three other directors had resigned ahead of the vote.

Fortis has been in the middle of a five-way bidding war with local and international suitors wanting to invest in the firm or buy it.

Manipal sweetened its offer for a fifth time after the Hero-Burman offer was selected, and IHH extended the acceptance period for its offer. REUTERS

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to